Lancet

• Latest
• Best
• Search…

• Lancet · Mar 2022

  Califf takes the helm at the US FDA, again.

  no abstract available

  read more… or not…

• Lancet · Mar 2022

  Department of Error.

  no abstract available

  keep reading… or just mark as read…

• Lancet · Mar 2022

  Comment

  Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.

  Placement of an interatrial shunt device reduces pulmonary capillary wedge pressure during exercise in patients with heart failure and preserved or mildly reduced ejection fraction. We aimed to investigate whether an interatrial shunt can reduce heart failure events or improve health status in these patients. ⋯ Corvia Medical.

  read on… or not…

• Lancet · Mar 2022

  A disclosure form for work submitted to medical journals: a proposal from the International Committee of Medical Journal Editors.

  no abstract available

  read more… or not…

• Lancet · Mar 2022

  Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.

  We aimed to assess the effectiveness of a single dose of the Ad26.COV2.S vaccine (Johnson & Johnson) in health-care workers in South Africa during two waves of the South African COVID-19 epidemic. ⋯ National Treasury of South Africa, the National Department of Health, Solidarity Response Fund NPC, The Michael & Susan Dell Foundation, The Elma Vaccines and Immunization Foundation, and the Bill & Melinda Gates Foundation.

  read more… mark as read…